Agree I think that is a risk given the very strong position but early positions Inoviq has with the SubB2M results and with an Exosomes product in the early stages of commercialisation. My opinion only but looks very cheap and I have been constantly beating on about management communicating with the market and urgency in getting to the next stages of development and commercialisation.
DYOR but the won’t be getting any of my shares .
Agree I think that is a risk given the very strong position but...
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.30M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 46.0¢ | 45.5¢ | $41.74K | 91.54K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18000 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 1195 | 1 |
View Market Depth
| Last trade - 14.32pm 01/11/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |